May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...
May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc. HeartLight ...
May 16, 2019 — CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the ...
April 16, 2019 — CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation ...
May 17, 2018 — Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 ...
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Balloon ...
August 7, 2017 — CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three ...
Aug. 1, 2017 — The Japanese Ministry of Health, Labour and Welfare has granted Japanese market clearance for the ...
January 25, 2017 — CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur ...
January 12, 2015 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial ...